Stock listing
Genprex, Inc.
Selected listing: 2DE · GETTEX · EUR · DE
Genprex, Inc. (gettex:2DE), Health Technology. Latest release Sep 8, 2026: Genprex to Present at the H.C. Wainwright 28th Annual Global Investment Conference.
- Ticker
- gettex:2DE
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- gettex
- Currency
- EUR
About Genprex, Inc.
Genprex, Inc. (GNPX) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.
Latest news from Genprex, Inc.
Genprex to Present at the H.C. Wainwright 28th Annual Global Investment Conference
September 8, 2026
Andelyn Biosciences to Scale Manufacturing for Genprex's Diabetes Gene Therapy Program
September 1, 2026
Genprex Selects Leading Clinical and Commercial Contract Development and Manufacturing Organization for Manufacturing Scale Up of Diabetes Gene Therapy
August 18, 2026
Genprex Announces Collaboration with Roche Diagnostics for Biomarker Assay Validation Studies
August 3, 2026
Genprex Receives a Notice of Allowance from The Canadian Intellectual Property Office for a Patent Claiming the Combination of Reqorsa® Gene Therapy with Either PD-1 or PD-L1 Antibodies to Treat Cancer
June 22, 2026
Research Genprex, Inc.
Alternate listings
GNPX:NASDAQ
US · USD
Alternate listing for Genprex, Inc.; the primary context on this page is 2DE:GETTEX.
GNPX:BOATS
US · USD
Alternate listing for Genprex, Inc.; the primary context on this page is 2DE:GETTEX.
2DE:FWB
DE · EUR
Alternate listing for Genprex, Inc.; the primary context on this page is 2DE:GETTEX.
0A8I:LSE
GB · USD
Alternate listing for Genprex, Inc.; the primary context on this page is 2DE:GETTEX.
2DE:MUN
DE · EUR
Alternate listing for Genprex, Inc.; the primary context on this page is 2DE:GETTEX.